Purification, molecular cloning, heterologous expression and characterization of pig CYP1A2

References

• Agundez JAG, Luengo A, Benitez J. Caffeine demethylase activity in human and dark agouti rat liver microsomes. Drug Metabolism and Disposition 1992; 20: 343–349
   PubMed Web of Science ®Google Scholar
• Amato G, Longo V, Mazzaccaro A, Gervasi PG. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Chemical Research and Toxicology 1996; 9: 882–890
   PubMed Web of Science ®Google Scholar
• Anzenbacher P, Soucek P, Anzenbacherova E, Gut I, Hruby K, Svoboda Z, Kvetina J. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Drug Metabolism and Disposition 1998; 26: 56–59
   PubMed Web of Science ®Google Scholar
• Baranova J, Anzenbacherova E, Anzenbacher P, Soucek P. Minipig cytochrome P450 2E1: Comparison with human enzyme. Drug Metabolism and Disposition 2005; 33: 862–865
   PubMed Web of Science ®Google Scholar
• Buther MA, Iwasaki M, Guengerich FP, Kadlubar FF. Human cytochrome P450PA (P4501A2), the phenacetin O-deethylase is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic aryl amines. Proceedings of the National Academy of Sciences, USA 1989; 86: 7696–7700
   PubMed Web of Science ®Google Scholar
• Chari MH, Collins BH, Magee JC, Di Maio JM, Kirk AD, Harland RC, McCann RL, Platt JL, Meyers WC. Brief report: Treatment of hepatic failure with ex vivo pig liver perfusion followed by liver transplantation. New England Journal of Medicine 1994; 331: 234–237
   PubMed Web of Science ®Google Scholar
• Donato MT, Castell JV, Gomez-Lechon MJ. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: Comparison with other hepatic cellular models. Journal of Hepatology 1999; 31: 542–549
   PubMed Web of Science ®Google Scholar
• Fisher CV, Caudle DL, Martin-Wixtrom C, Quattrochi LC, Tukey RH, Waterman MR, Estabrook RW. High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein. FASEB Journal 1992; 6: 759–764
   PubMed Web of Science ®Google Scholar
• Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analysis of amino acid and coding nucleotide sequences. Journal Biological Chemistry 1992; 267: 83–90
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chemico-Biological Interaction 1997; 106: 161–182
   PubMed Web of Science ®Google Scholar
• John GH, Hasler JA, He Y, Halpert JR. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B. Archives Biochemistry and Biophysics 1994; 314: 367–375
   PubMed Web of Science ®Google Scholar
• Kemper B. Structural basis for the role in protein folding of the conserved prolin-rich regions in cytochrome P450. Toxicology and Applied Pharmacology 2004; 199: 305–315
   PubMed Web of Science ®Google Scholar
• Kim D-H, Kim K-H, Isin K, Guengerich FP, Chae HZ, Ahn T, Yun C-H. Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli. Protein Expression and Purification 2008; 57: 188–200
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Lewis DFV, Lake BG. Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: Rationalization of CYP1A substrate specificity in terms of active site amino acid residues. Xenobiotica 1996; 26: 723–753
   PubMed Web of Science ®Google Scholar
• Lin Z, Lou Y, Squires EJ. Molecular cloning, expression and functional characterization of the cytochrome P450 2A6 gene in pig liver. Animal Genetics 2004; 35: 312–316
   Web of Science ®Google Scholar
• Liu J, Ericksen SS, Sivaneri M, Besspiata D, Fisher CW, Szklarz GD. The effect of reciprocal active site mutations in human cytochrome P4501A1 and 1A2 on alkoxyresorufin metabolism. Archives of Biochemistry and Biophysics 2004; 424: 33–43
   PubMed Web of Science ®Google Scholar
• Longo V, Mazzaccaro A, Naldi F, Gervasi PG. Drug metabolizing enzymes in liver, olfactory and respiratory epithelium of cattle. Journal of Biochemical and Toxicology 1991; 6: 123–128
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. Journal Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Lubet RA, Mayer RT, Cameron JW, Nims RW, Burke MD, Wolf T, Guengerich FP. Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Archives Biochemistry and Biophysics 1985; 238: 43–48
   PubMed Web of Science ®Google Scholar
• Lundell K. Cloning and expression of two novel pig liver and kidney fatty acid hydroxylases [cytochrome P450 (CYP)4A24 and CYP4A25]. Journal of Biochemistry 2002; 363: 297–303
   Google Scholar
• Marini S, Longo V, Mazzaccaro A, Gervasi PG. Xenobiotic metabolizing enzymes in pig nasal and hepatic tissues. Xenobiotica 1998; 10: 923–935
   Web of Science ®Google Scholar
• Mise M, Hashizume T, Matsumoto S, Terauchi Y, Fujii T. Identification of non-functional allelic variant CYP1A2 in dogs. Pharmacology and Genomics 2004; 14: 769–773
   Google Scholar
• Myers MJ, Farrell DE, Howard KD, Kawalek JC. Identification of multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine. Drug Metabolism and Disposition 2001; 29: 908–915
   PubMed Web of Science ®Google Scholar
• Narimatsu S, Oda M, Hichiya H, Isobe T, Asaoka K, Hanioka N, Yamano S, Shinoda S. Yamamoto S. Molecular cloning and functional analysis of cytochrome P4501A2 from Japanese monkey liver: Comparison with marmoset cytochrome P450 1A2. Chemico-Biological Interaction 2005; 152: 1–12
   PubMed Web of Science ®Google Scholar
• Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, et al. P-450 superfamily: Update on new sequence, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1–42
   PubMedGoogle Scholar
• Niimi S, Watanabe MX, Kim E, Iwata H, Ysunaga G, Fujise Y, Tanabe S. Molecular cloning and mRNA expression of cytochrome P4501A1 and 1A2 in the liver of common minke whale (Balaenoptera acutorostrata). Marine Pollution Bulletin 2005; 51: 784–793
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. The carbon-monoxide binding protein of liver microsomes. I. Evidences for its hemoprotein nature. Journal Biological Chemistry 1964; 293: 2370–2378
   Google Scholar
• Ono S, Hatanaka T, Hotta H, Satoh T, Gonzalez FJ, Tsutsui M. Specificity of substrate and inhibitor probes for cytochrome P450s: Evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 1996; 26: 681–693
   PubMed Web of Science ®Google Scholar
• Puccini P, Menicagli S, Longo V, Santucci A, Gervasi PG. Purification and characterization of an acetone-inducible cytochrome P450 from hamster liver microsomes. Biochemical Journal 1992; 287: 863–870
   PubMed Web of Science ®Google Scholar
• Rendic S, Di Carlo FJ. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metabolism Review 1997; 9: 413–580
   Web of Science ®Google Scholar
• Ryan DE, Levin W. Purification and characterisation of hepatic microsomal cytochrome P450. Pharmacology and Therapeutics 1990; 45: 153–239
   PubMed Web of Science ®Google Scholar
• Ryan DE, Thomas PE, Lewin W. Hepatic microsomal cytochrome P450 from rat treated with isosafrole. Journal of Biology and Chemistry 1980; 255: 7941–7955
   PubMed Web of Science ®Google Scholar
• Sakuma T, Igarashi T, Hieda M, Ohgiya S, Isogai M, Ninomya S, Nagata R, Nemoto N, Kamataki M. Marmoset CYP1A2: Primary structure and constitutive expression in livers. Carcinogenesis 1997; 18: 1985–1991
   PubMed Web of Science ®Google Scholar
• Sakuma T, Shinojima T, Miwa K, Kamataki T. Short Communication: Cloning CYP2D21 and CYP3A22 cDNAs from liver of miniature pigs. Drug Metabolism and Disposition 2004; 32: 376–378
   PubMed Web of Science ®Google Scholar
• Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF. Adaptation for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P4501A2. Journal Biological Chemistry 2007; 282: 14341–14355
   Web of Science ®Google Scholar
• Skaanild MT. Porcine cytochrome P450 and metabolism. Current Pharmacology Design 2006; 12: 1421–1427
   PubMed Web of Science ®Google Scholar
• Skaanild MT, Friis C. Cytochrome P450 sex differences in minipigs and conventional pigs. Pharmacology and Toxicology 1999; 85: 174–180
   PubMedGoogle Scholar
• Soucek P, Zuber R, Anzenbacherova E, Anzenbacher P, Guengerich FP. Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacology 2001; 1: 11–19
   PubMedGoogle Scholar
• Swindle MM, Smith AC. Comparative anatomy and physiology of the pig. Scandinavian Journal Laboratory. Animal Sciences Suppl. 1998; 25: 11–22
   Web of Science ®Google Scholar
• Tanaka N, Miyasho T, Shinkyo R, Sakaki T, Yokota H. cDNA cloning and characterization of feline CYP1A1 and CYP1A2. Life Science 2006; 79: 2463–2473
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W, Birkett DL, Veronese ME, McManus ME, Tukey RH, Quattrochi LC, Gelboin HV, Miners JO. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Journal of Pharmacology and Experimental Therapeutics 1993; 265: 401–407
   PubMed Web of Science ®Google Scholar
• Thomsen MK, Friis C, Nielsen P. Purification and characterization of hepatic microsomal cytochrome P-450 in phenobarbital- and beta-naphthoflavone-treated pigs. Pharmacology and Toxicology 1991; 69: 381–385
   PubMedGoogle Scholar
• Towbin HT, Staehelin P, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences, USA 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Tsyrlov IB, Goldfarb IS, Gelboin HV. Enzyme–kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal and purified CYP1A1 and CYP1A2. Archives Biochemistry and Biophysics 1993; 307: 259–266
   PubMed Web of Science ®Google Scholar
• Uchida T, Komori M, Kitada M, Kamataki T. Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P450 from polychlorinated biphenyl-treated beagle dogs. Molecular Pharmacology 1990; 38: 6434–6465
   Web of Science ®Google Scholar
• Vanderslice RR, Domin BA, Carver GT, Philpot RM. Species dependent expression and induction of homologous of rabbit cytochrome P450 isozyme 5 in liver and lung. Molecular Pharmacology 1987; 31: 320–325
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Archives Biochemistry and Biophysics 1991; 290: 160–166
   PubMed Web of Science ®Google Scholar